Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allogeneic natural killer cells PB103

A preparation of allogeneic, natural killer (NK) cells, with potential cytolytic and antineoplastic activities. Upon administration, allogeneic NK cells PB103 may lyse cancer cells. These cells also secrete pro-inflammatory cytokines, which further stimulate an anti-tumor immune response.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	allogeneic NK Cells PB103 allogeneic NKs PB103
Code name:	PB 103 PB-103 PB103

allogeneic natural killer cells PB103

Search NCI's Drug Dictionary